A case of ceftriaxone-induced immune haemolytic anaemia in an ambulatory care setting

A case of ceftriaxone-induced immune haemolytic anaemia in an ambulatory care setting

Background: Drug-induced immune haemolytic anaemia (DIIHA) is a rare adverse effect which varies between mild to fatal (Garratty, 2010). One of the most common class of drugs reported to cause severe DIIHA are the second and third generation cephalosporins (e.g. ceftriaxone) (Garratty, 2010; Hill et...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí: Rakhee Mistry, Luke S.P. Moore, Nabeela Mughal, Andrew Godfrey, Stephen Hughes
Formáid: Alt
Teanga:English
Foilsithe / Cruthaithe: Elsevier 2024-01-01
Sraith:Clinical Infection in Practice
Ábhair:
Ceftriaxone
Drug-induced immune haemolytic anaemia
Bacterial infections
Outpatient parenteral antimicrobial therapy
Rochtain ar líne:http://www.sciencedirect.com/science/article/pii/S2590170224000013

Ar líne

http://www.sciencedirect.com/science/article/pii/S2590170224000013

Míreanna comhchosúla